This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Cytotoxic Drugs Market

Market Insights on Cytotoxic Drugs covering sales outlook, demand forecast & up-to-date key trends

Cytotoxic Drugs Market by Product Type (Branded Drugs, Generic Drugs), Drug Type (Alkylating Agents, Antitumor Antibiotics, Antimetabolites, Plant Alkaloids, Others), Route of Administration (Oral, Parenteral), End User (Hospitals, Cancer Research Centres, Drug Testing Laboratories, CDMOs) & Region - Forecast 2022 - 2028

Cytotoxic Drugs Market Outlook (2022-2028)

[338 Pages Report] The global Cytotoxic Drugs Market is expected to account for a valuation of US$ 16.2 Bn in 2022, and rise at a sluggish CAGR of 0.9% to reach an estimated net worth of US$ 17.1 Bn by the end of 2028.

Cytotoxic Drugs Market Size (2022)

US$ 16.2 Bn

Revenue Forecast (2028)

US$ 17.1 Bn (2028)

Global Market Growth Rate (2022-2028)

0.9% CAGR

Regional Market With Largest Share

North America – 41.8%

Top 5 Cytotoxic Medication Manufacturers

Johnson and Johnson, Pfizer, Teva Pharmaceutical, Mylan NV, Fresenius Kabi AG

Classification of cytotoxic drugs as per alkylating agents, antitumor antibiotics, antimetabolites, etc., has been studied in this cytotoxic drugs research report by Future Market Insights (FMI). Cytotoxic drugs are also known as antineoplastic drugs.

Sales of cytotoxic drugs account for around 13.4% share of the global oncology drugs and therapeutics market. Cytotoxic drug side effects are well known and have restrained the market from reaching its optimal revenue potential

Customize this Report

Let us know your requirement to get
100% FREE customization

Consumption Analysis of Cytotoxic Drugs (2013 to 2021) Vs Market Estimates (2022 to 2028)

The world has seen a substantial rise in the use of drugs for medical treatment as the prevalence of chronic diseases has increased. Instances of cancer have risen substantially across the globe, and this has increased demand for cancer drugs and cancer therapies for its treatment. Cytotoxic drugs are the first choice and first line of defence in the treatment of cancer via chemotherapy.

The cytotoxic drugs market saw expansion at a CAGR of 1% from 2013 to 2021, and held a net worth of US$ 16 Bn in 2021.

Cytotoxic Drugs Market Download Report Brochure

Sales of cytotoxic medicines have seen a rise over the past decade but the growth is expected to slow down as new treatment methods are popularized. The cytotoxic drug side effects are one of the major factors that restrain their sales and usage. The potential damage caused by exposure to cytotoxic drugs has led to skepticism around their usage. Some of the side effects include nausea, dizziness, hair loss, infection, constipation, etc.

On the basis of classification, cytotoxic drugs can be used for multiple cancer treatment applications. Cytotoxic drug classification by alkylating agents, antitumor antibiotics, antimetabolites, plant alkaloids, and others is detailed in this cytotoxic drugs market survey. Demand for cytotoxic drugs is anticipated to rise at a sluggish CAGR of 0.9% from 2022 to 2028.

How is the Cytotoxic Drugs Industry Expected to Perform across Major Regions?

This global cytotoxic medication industry analysis provides detailed insights across multiple geographies such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).

The North American cytotoxic drug products market is expected to hold a dominant global market share of 41.8% and is anticipated to keep this up over the forecast period as well. Rising cancer awareness and increasing research & development by prominent cytotoxic drug manufacturers are some major factors driving the market growth in this region.

Demand for cytotoxic drugs is expected to rise rapidly in East Asia, South Asia, and the Pacific, and collectively, these regions would hold a market share of 21.5% on a global scale in 2022. Cytotoxic drugs consumption in these regions are expected to be driven by aspects such as rising demand for multiple cancer drugs, increasing awareness, government initiatives that are backing the research & development of antineoplastic drugs, etc.

The cytotoxic medicines market in Europe is predicted to hold around 28.1% share of the global marketplace in 2022. Increasing incidence of cancer in the region are expected to majorly influence the sales of cytotoxic drugs.

Cytotoxic drugs demand in the MEA region is expected to see a steady rise over the forecast period as the healthcare infrastructure in this region develops and awareness about cancer rises.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Analysis

How are Sales of Cytotoxic Drugs Expected to Shape Up in the U.S.?

The U.S. cytotoxic drugs market is one with high potential, and this is due to the high prevalence of multiple cancer cases in the nation. The U.S. has seen a huge rise in cancer cases in the past couple of decades, which can be attributed to decreasing quality of lifestyle, rising prevalence of obesity, etc.

Demand for cytotoxic drugs in the U.S. is expected to be driven by increasing cancer awareness and rising geriatric population in the nation. Its developed and advanced healthcare infrastructure creates a lucrative setting for the sales of cytotoxic drugs in the U.S.

Why Should Cytotoxic Drugs Producers Focus on India?

India has seen a rise in the number of cancer instances over the past few years, and there has also been an increase in awareness about the disease and its treatment. The nation has a massive population and a rapidly developing healthcare infrastructure that promotes demand for cytotoxic drugs as awareness for the treatment of cancer increases.

India is also a favourable market for cytotoxic drugs manufacturers as it provides low manufacturing costs and favourable regulations, which make drug approvals fairly easy in comparison to other nations.

Cytotoxic Drugs Market - Category-wise Analysis

Which End User Accounts for Majority Sales of Antineoplastic Drugs?

Use of cytotoxic drugs is usually the first aspect of cancer treatments and is one of the much-known cancer treatment methods. Most injectable cytotoxic drugs are administered by healthcare professionals since it is required to do it in a safe manner and improper administration could lead to harmful cytotoxic drugs side effects which can be as severe as damage to chromosomes when in direct contact with an individual.

Hence, majority of demand for antineoplastic drugs is driven by hospitals.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

COVID-19 Impact Analysis

In 2020, when coronavirus infections surged globally, the world saw some major changes that were never expected by anyone. As infections spread across the world, in an effort to contain the spread lockdowns were imposed on a global scale and the world came to a halt like never before. This drastically affected multiple markets and most markets toppled under the sudden change and lockdown restrictions which ceased operations to a drastic extent.

The healthcare industry was the only industry that benefited from the pandemic along with some other industry verticals. The cytotoxic drugs space was one of the few markets that did not see a negative impact of the COVID-19 pandemic and managed to get through the pandemic phase with relative ease than most markets.

Demand for cytotoxic drugs saw a rise and is expected to show a positive outlook over the post-pandemic era as well citing the prevalence of different types of cancers.

Cytotoxic Drugs Market - Competitive Landscape

Cytotoxic drug manufacturers are focusing on mergers and collaborations to increase their research scope to develop new drugs that cater to most cancers and meet regulations of multiple countries. Cytotoxic drug companies are also focusing on increasing awareness about the use of antineoplastic drugs to treat cancer.

  • In May 2021, Zydus Cadila a pharmaceutical subsidiary of Zydus group, announced the launch of its new drug for breast cancer treatment in India. Trastuzumab Emtansine is said to be the first targeted chemotherapy drug for breast cancer that is capable of directing cytotoxic activity towards cancer cells with the use of a biomarker.
  • In October 2021, NanoString Technologies Inc., a major name in the life science tools industry, announced the launch of a new gene expression tool that would aid in the rapid expansion of the Antibody Drug Conjugates (ADCs) field. This new nCounter® ADC Development Panel would aid in developing drugs that can differentiate healthy and cancer tissues with cytotoxic drug’s cell-killing abilities, and hence reduce the side effects on healthy tissues and cells.

Cytotoxic Drugs Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Product Type
  • End User
  • Route of Administration
  • Drug Type
  • Region

Key Companies Profiled

  • CytoPharma
  • Bristol-Myers Squibb
  • Amgen Inc.
  • Celgene Corp.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Johnson and Johnson
  • Lonza
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer
  • Sanofi
  • Teva Pharmaceutical

Pricing

Available upon Request

Key Segments of Cytotoxic Drugs Industry Survey

Cytotoxic Drugs Market by Product Type:

  • Branded Drugs
  • Generic Drugs

Cytotoxic Drugs Market by End User:

  • Hospitals
  • Cancer Research Centres
  • Drug Testing Laboratories
  • CDMOs

Cytotoxic Drugs Market by Route of Administration:

  • Oral Cytotoxic Drugs
  • Parenteral Cytotoxic Drugs

Cytotoxic Drugs Market by Drug Type:

  • Alkylating Agents
  • Antitumor Antibiotics
  • Antimetabolites
  • Plant Alkaloids
  • Others

Cytotoxic Drugs Market by Region:

  • North America Cytotoxic Drugs Market
  • Latin America Cytotoxic Drugs Market
  • Europe Cytotoxic Drugs Market
  • East Asia Cytotoxic Drugs Market
  • South Asia & Pacific Cytotoxic Drugs Market
  • Middle East & Africa (MEA) Cytotoxic Drugs Market

Frequently Asked Questions

Cytotoxic drugs contain chemicals that are toxic to cells, thereby preventing their replication.

The global cytotoxic drugs market is predicted to be valued at US$ 16.2 Bn in 2022.

The North American cytotoxic drugs market holds a dominant market share of 41.8% in the global landscape.

As per FMI analysis, the cytotoxic drugs market is set to progress at a CAGR of 0.9% over the forecast period of 2022 to 2028.

CytoPharma, Bristol-Myers Squibb, Amgen Inc., Celgene Corp., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson and Johnson, Lonza, and Merck & Co. Inc. are major producers of cytotoxic drugs.

The cytotoxic drugs market is projected to attain a revenue of US$ 17.1 Bn by 2028.

Table of Content

1. Executive Summary

A gist of the report, highlighting the key takeaways

     1.1. Market Overview

     1.2. Market Analysis

     1.3. FMI Analysis and Recommendations

     1.4. Wheel of Fortune

2. Market Introduction A definition of Cytotoxic Drugs Market and related market taxonomy

     2.1. Market Taxonomy

     2.2. Market Definition

3. Market Background

     3.1. Market Dynamics

           3.1.1. Drivers

           3.1.2. Restraints

           3.1.3. Opportunity Analysis

           3.1.4. Trends

     3.2. Macroeconomic Assumptions

     3.3. Global Economic Outlook

4. Market Overview

     4.1. Market Outlook

     4.2. Key Inclusions

           4.2.1. Pipeline analysis

           4.2.2. Regulations

           4.2.3. Toxicity Classification (SafeBridge)

           4.2.4. Outlook on cytotoxic requirements in drug conjugation

           4.2.5. Standards for the safe handling of cytotoxic drugs

           4.2.6. Snapshot Of Cancer Cases

5. North America Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028 Market forecast and analysis in the U.S. and Canada

     5.1. Introduction

     5.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

           5.2.1. U.S.

           5.2.2. Canada

     5.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

     5.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

           5.4.1. Alkylating Agents

           5.4.2. Antitumor Antibiotics 

           5.4.3. Antimetabolites

           5.4.4. Plant Alkaloids

           5.4.5. Others 

     5.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     5.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           5.6.1. Oral

           5.6.2. Parenteral

     5.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     5.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           5.8.1. Branded Drugs

           5.8.2. Generic Drugs 

     5.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     5.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           5.10.1. Hospital

           5.10.2. Cancer Research Center

           5.10.3. Drug Testing Laboratory

           5.10.4. CDMOs

     5.11. Market Size (US$ Mn) Forecast By End User, 2022–2028

     5.12. Market Attractiveness Analysis

           5.12.1. By Country

           5.12.2. By Drug Type

           5.12.3. By Route Of Administration

           5.12.4. By Product Type

           5.12.5. By End User

     5.13. Key Market Participants – Intensity Mapping

     5.14. Drivers and Restraints – Impact Analysis

6. Western Europe Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028

Market forecast and analysis in the Western European Countries

     6.1. Introduction

     6.2. Historical Market Size (US$ Mn) By Country, 2013–2021

           6.2.1. Germany

           6.2.2. France

           6.2.3. U.K.

           6.2.4. Spain

           6.2.5. Italy

           6.2.6. BENELUX

           6.2.7. Nordics

           6.2.8. Rest of Western Europe

     6.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

     6.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

           6.4.1. Alkylating Agents

           6.4.2. Antitumor Antibiotics 

           6.4.3. Antimetabolites

           6.4.4. Plant Alkaloids

           6.4.5. Others 

     6.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     6.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           6.6.1. Oral

           6.6.2. Parenteral

     6.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     6.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           6.8.1. Branded Drugs

           6.8.2. Generic Drugs 

     6.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     6.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           6.10.1. Hospital

           6.10.2. Cancer Research Center

           6.10.3. Drug Testing Laboratory

           6.10.4. CDMOs

     6.11. Market Size (US$ Mn) Forecast By End User, 2022–2028

     6.12. Market Attractiveness Analysis

           6.12.1. By Country

           6.12.2. By Drug Type

           6.12.3. By Route Of Administration

           6.12.4. By Product Type

           6.12.5. By End User 

     6.13. Key Market Participants – Intensity Mapping

     6.14. Drivers and Restraints – Impact Analysis

7. Eastern Europe Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028

Market forecast and analysis in the Eastern European countries

     7.1. Introduction

     7.2. Historical Market Size (US$ Mn) By Country, 2013–2021

           7.2.1. Russia

           7.2.2. Poland

           7.2.3. Rest of Eastern Europe

     7.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

     7.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

           7.4.1. Alkylating Agents

           7.4.2. Antitumor Antibiotics 

           7.4.3. Antimetabolites

           7.4.4. Plant Alkaloids

           7.4.5. Others 

     7.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     7.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           7.6.1. Oral

           7.6.2. Parenteral

     7.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     7.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           7.8.1. Branded Drugs

           7.8.2. Generic Drugs 

     7.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     7.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           7.10.1. Hospital

           7.10.2. Cancer Research Center

           7.10.3. Drug Testing Laboratory

           7.10.4. CDMOs

     7.11. Market Size (US$ Mn) Forecast By End User, 2022–2028

     7.12. Market Attractiveness Analysis

           7.12.1. By Country

           7.12.2. By Drug Type

           7.12.3. By Route Of Administration

           7.12.4. By Product Type

           7.12.5. By End User 

     7.13. Key Market Participants – Intensity Mapping

     7.14. Drivers and Restraints – Impact Analysis

8. Latin America Cytotoxic Drugs Market   Analysis 2013–2021 and Forecast 2022–2028

Market forecast and analysis in Latin American countries

     8.1. Introduction

     8.2. Historical Market Size (US$ Mn) By Country, 2013–2021

           8.2.1. Brazil

           8.2.2. Mexico

           8.2.3. Rest of Latin America

     8.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

     8.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

           8.4.1. Alkylating Agents

           8.4.2. Antitumor Antibiotics 

           8.4.3. Antimetabolites

           8.4.4. Plant Alkaloids

           8.4.5. Others 

     8.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     8.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           8.6.1. Oral

           8.6.2. Parenteral

     8.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     8.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           8.8.1. Branded Drugs

           8.8.2. Generic Drugs 

     8.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     8.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           8.10.1. Hospital

           8.10.2. Cancer Research Center

           8.10.3. Drug Testing Laboratory

           8.10.4. CDMOs

     8.11. Market Size (US$ Mn) Forecast By End User, 2022–2028

     8.12. Market Attractiveness Analysis

           8.12.1. By Country

           8.12.2. By Drug Type

           8.12.3. By Route Of Administration

           8.12.4. By Product Type

           8.12.5. By End User 

     8.13. Key Market Participants – Intensity Mapping

     8.14. Drivers and Restraints – Impact Analysis

9. Asia Pacific excluding Japan and China (APEJC) Cytotoxic Drugs Market   Analysis 2013–2021 and Forecast 2022–2028

Market forecast and analysis in the Asia Pacific countries excluding China and Japan

     9.1. Introduction

     9.2. Historical Market Size (US$ Mn) By Country, 2013–2021

           9.2.1. India

           9.2.2. Australia and New Zealand

           9.2.3. ASEAN

           9.2.4. Rest of APEJ

     9.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

     9.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

           9.4.1. Alkylating Agents

           9.4.2. Antitumor Antibiotics 

           9.4.3. Antimetabolites

           9.4.4. Plant Alkaloids

           9.4.5. Others 

     9.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     9.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           9.6.1. Oral

           9.6.2. Parenteral

     9.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     9.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           9.8.1. Branded Drugs

           9.8.2. Generic Drugs 

     9.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     9.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           9.10.1. Hospital

           9.10.2. Cancer Research Center

           9.10.3. Drug Testing Laboratory

           9.10.4. CDMOs

     9.11. Market Size (US$ Mn) Forecast By End User, 2022–2028

     9.12. Market Attractiveness Analysis

           9.12.1. By Country

           9.12.2. By Drug Type

           9.12.3. By Route Of Administration

           9.12.4. By Product Type

           9.12.5. By End User

     9.13. Key Market Participants – Intensity Mapping

     9.14. Drivers and Restraints – Impact Analysis

10. Japan Cytotoxic Drugs Market   Analysis 2013–2021 and Forecast 2022–2028

Market forecast and analysis in Japan

     10.1. Introduction

     10.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

           10.2.1. Alkylating Agents

           10.2.2. Antitumor Antibiotics 

           10.2.3. Antimetabolites

           10.2.4. Plant Alkaloids

           10.2.5. Others 

     10.3. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     10.4. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           10.4.1. Oral

           10.4.2. Parenteral

     10.5. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     10.6. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           10.6.1. Branded Drugs

           10.6.2. Generic Drugs 

     10.7. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           10.8.1. Hospital

           10.8.2. Cancer Research Center

           10.8.3. Drug Testing Laboratory

           10.8.4. CDMOs

     10.9. Market Size (US$ Mn) Forecast By End User, 2022–2028

     10.10. Market Attractiveness Analysis

           10.10.1. By Drug Type

           10.10.2. By Route Of Administration

           10.10.3. By Product Type

           10.10.4. By End User

     10.11. Key Market Participants – Intensity Mapping

     10.12. Drivers and Restraints – Impact Analysis

11. China Cytotoxic Drugs Market  Analysis 2013–2021 and Forecast 2022–2028

Market forecast and analysis in China

     11.1. Introduction

     11.1. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

           11.1.1. Alkylating Agents

           11.1.2. Antitumor Antibiotics 

           11.1.3. Antimetabolites

           11.1.4. Plant Alkaloids

           11.1.5. Others 

     11.2. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     11.3. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           11.3.1. Oral

           11.3.2. Parenteral

     11.4. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           11.5.1. Branded Drugs

           11.5.2. Generic Drugs 

     11.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     11.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           11.7.1. Hospital

           11.7.2. Cancer Research Center

           11.7.3. Drug Testing Laboratory

           11.7.4. CDMOs

     11.8. Market Size (US$ Mn) Forecast By End User, 2022–2028

     11.9. Market Attractiveness Analysis

           11.9.1. By Drug Type

           11.9.2. By Route Of Administration

           11.9.3. By Product Type

           11.9.4. By End User

     11.10. Key Market Participants – Intensity Mapping

     11.11. Drivers and Restraints – Impact Analysis

12. MEA Cytotoxic Drugs Market   Analysis 2013–2021 and Forecast 2022–2028

Market forecast and analysis in MEA countries focusing on GCC and South Africa

     12.1. Introduction

     12.2. Historical Market Size (US$ Mn) By Country, 2013–2021

           12.2.1. GCC Countries

           12.2.2. South Africa

           12.2.3. Rest of MEA

     12.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

     12.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

           12.4.1. Alkylating Agents

           12.4.2. Antitumor Antibiotics 

           12.4.3. Antimetabolites

           12.4.4. Plant Alkaloids

           12.4.5. Others 

     12.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     12.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           12.6.1. Oral

           12.6.2. Parenteral

     12.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     12.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           12.8.1. Branded Drugs

           12.8.2. Generic Drugs 

     12.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     12.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           12.10.1. Hospital

           12.10.2. Cancer Research Center

           12.10.3. Drug Testing Laboratory

           12.10.4. CDMOs

     12.11. Market Size (US$ Mn) Forecast By End User, 2022–2028

     12.12. Market Attractiveness Analysis

           12.12.1. By Country

           12.12.2. By Drug Type

           12.12.3. By Route Of Administration

           12.12.4. By Product Type

           12.12.5. By End User

     12.13. Participants – Intensity Mapping

     12.14. Drivers and Restraints – Impact Analysis

13. Forecast Factors: Relevance and Impact

14. Competition Analysis

     14.1. Competition Dashboard

     14.2. Company Deep Dive

       14.2.1. CytoPharma

                14.2.1.1. Overview

                14.2.1.2. Product and Application Portfolio

               14.2.1.3. Channel Footprint

               14.2.1.4. Strategy

                    14.2.1.4.1. Marketing Strategy

                    14.2.1.4.2. Product Strategy

                    14.2.1.4.3. Channel Strategy

           14.2.2. Bristol-Myers Squibb

                     14.2.2.1. Overview

                     14.2.2.2. Product and Application Portfolio

                     14.2.2.3. Channel Footprint

                     14.2.2.4. Strategy

                    14.2.2.4.1. Marketing Strategy

                    14.2.2.4.2. Product Strategy

                     14.2.2.4.3. Channel Strategy

           14.2.3. Amgen Inc.

                     14.2.3.1. Overview

                     14.2.3.2. Product and Application Portfolio

                     14.2.3.3. Channel Footprint

                     14.2.3.4. Strategy

                    14.2.3.4.1. Marketing Strategy

                    14.2.3.4.2. Product Strategy

                    14.2.3.4.3. Channel Strategy

           14.2.4. Celgene Corp. 

                     14.2.4.1.  Overview

                     14.2.4.2. Product and Application Portfolio

                     14.2.4.3. Channel Footprint

                     14.2.4.4. Strategy

                                 14.2.4.4.1. Marketing Strategy

                                 14.2.4.4.2. Product Strategy

                                 14.2.4.4.3. Channel Strategy

                                 14.2.4.4.3.1. 

           14.2.5. Eli Lilly and Company

                     14.2.5.1.  Overview

                     14.2.5.2. Product and Application Portfolio

                     14.2.5.3. Channel Footprint

                     14.2.5.4. Strategy

                                 14.2.5.4.1. Marketing Strategy

                                 14.2.5.4.2. Product Strategy

                                 14.2.5.4.3. Channel Strategy

           14.2.6. F. Hoffmann-La Roche AG 

                     14.2.6.1.  Overview

                     14.2.6.2. Product and Application Portfolio

                     14.2.6.3. Channel Footprint

                     14.2.6.4. Strategy

                                 14.2.6.4.1. Marketing Strategy

                                 14.2.6.4.2. Product Strategy

                                 14.2.6.4.3. Channel Strategy

           14.2.7. GlaxoSmithKline PLC

                     14.2.7.1. Overview

                     14.2.7.2. Product and Application Portfolio

                     14.2.7.3. Channel Footprint

                     14.2.7.4. Strategy

                                 14.2.7.4.1. Marketing Strategy

                                 14.2.7.4.2. Product Strategy

                                 14.2.7.4.3. Channel Strategy

           14.2.8. Johnson and Johnson

                14.2.8.1.  Overview

                14.2.8.2. Product and Application Portfolio

                14.2.8.3. Channel Footprint

                 14.2.8.4. Strategy

                    14.2.8.4.1. Marketing Strategy

                   14.2.8.4.2. Product Strategy

                    14.2.8.4.3. Channel Strategy

           14.2.9. Lonza

                14.2.9.1. Overview

               14.2.9.2. Product and Application Portfolio

               14.2.9.3. Channel Footprint

                14.2.9.4. Strategy

                    14.2.9.4.1. Marketing Strategy

                    14.2.9.4.2. Product Strategy

                    14.2.9.4.3. Channel Strategy

           14.2.10. Merck & Co., Inc.

                14.2.10.1. Overview

                14.2.10.2. Product and Application Portfolio

                14.2.10.3. Channel Footprint

               14.2.10.4. Strategy

                    14.2.10.4.1. Marketing Strategy

                    14.2.10.4.2. Product Strategy

                    14.2.10.4.3. Channel Strategy

           14.2.11.  Novartis AG

                14.2.11.1. Overview

                14.2.11.2. Product and Application Portfolio

                14.2.11.3. Channel Footprint

               14.2.11.4. Strategy

                    14.2.11.4.1. Marketing Strategy

                    14.2.11.4.2. Product Strategy

                    14.2.11.4.3. Channel Strategy

           14.2.12. Pfizer

                14.2.12.1. Overview

               14.2.12.2. Product and Application Portfolio

                14.2.12.3. Channel Footprint

                14.2.12.4. Strategy

                    14.2.12.4.1. Marketing Strategy

                   14.2.12.4.2. Product Strategy

                    14.2.12.4.3. Channel Strategy

           14.2.13. Sanofi

               14.2.13.1. Overview

                14.2.13.2. Product and Application Portfolio

               14.2.13.3. Channel Footprint

                14.2.13.4. Strategy

                    14.2.13.4.1. Marketing Strategy

                    14.2.13.4.2. Product Strategy

                    14.2.13.4.3. Channel Strategy

           14.2.14. Teva Pharmaceutical

                14.2.14.1. Overview

               14.2.14.2. Product and Application Portfolio

                14.2.14.3. Channel Footprint

                14.2.14.4. Strategy

                    14.2.14.4.1. Marketing Strategy

                    14.2.14.4.2. Product Strategy

                    14.2.14.4.3. Channel Strategy

15. Global Cytotoxic Drugs Market  Analysis 2013–2021 and Forecast 2022–2028, By Region

A detailed, region-wise assessment, providing projections on market growth in key regions

     15.1. Introduction / Key Findings

     15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2021 

           15.2.1. North America

           15.2.2. Western Europe

           15.2.3. Eastern Europe

           15.2.4. Latin America

           15.2.5. Asia Pacific excluding Japan and China

           15.2.6. Japan

           15.2.7. China

           15.2.8. Middle East and Africa

     15.3. Market Size (US$ Mn) Forecast By Region, 2022–2028

     15.4. Market Attractiveness Analysis By Region

16. Global Cytotoxic Drugs Market  Analysis 2013–2021 and Forecast 2022–2028, By Drug Type

Classification of Cytotoxic Drugs Market by Drug Type; highlighting historical trends, current market value, and future projections on the basis of key segments

     16.1. Introduction

     16.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Type, 2013–2021

           16.2.1. Alkylating Agents

           16.2.2. Antitumor Antibiotics 

           16.2.3. Antimetabolites

           16.2.4. Plant Alkaloids

           16.2.5. Others 

     16.3. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028

     16.4. Market Attractiveness Analysis By Drug Type

17. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028, By Route Of Administration

Classification of Cytotoxic Drugs Market by Route Of Administration; highlighting historical trends, current market value, and future projections on the basis of key segments

     17.1. Introduction

     17.2. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021

           17.2.1. Clinical Batch Production

           17.2.2. Commercial Production

     17.3. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028

     17.4. Market Attractiveness Analysis By Route Of Administration

18. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028, By Product Type 

Assessment of Product Type which is currently gaining traction, along with projections on how demand will shape up in the future

     18.1. Introduction

     18.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021

           18.2.1. Branded Drugs

           18.2.2. Generic Drugs 

     18.3. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

     18.4. Market Attractiveness Analysis By Product Type 

19. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028, By End User 

Assessment of end user segments currently gaining traction, along with projections on how demand will shape up in the future

     19.1. Introduction

     19.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

           19.2.1. Hospital

           19.2.2. Cancer Research Center

           19.2.3. Drug Testing Laboratory

           19.2.4. CDMOs

     19.3. Market Size (US$ Mn) Forecast By End User, 2022–2028

     19.4. Market Attractiveness Analysis By End User

20. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028

     20.1. Market Value Share Analysis 

           20.1.1. By Country

           20.1.2. By Drug Type

           20.1.3. By Route Of Administration

           20.1.4. By Product Type

           20.1.5. By End User

     20.2. Y-o-Y Growth Analysis

           20.2.1. By Country

           20.2.2. By Drug Type

           20.2.3. By Route Of Administration

           20.2.4. By Product Type

           20.2.5. By End User

     20.3. Absolute $ Opportunity

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 2: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 3: Ongoing clinical trials for cytotoxic drugs

Table 4: Cytotoxic Drugs in Markets Across The World

Table 5: Cytotoxic Agents and Specific Target

Table 6: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 7: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 8: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 9: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 10: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 11: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 12: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 13: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 14: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 15: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 16: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 17: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 18: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 19: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 20: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 21: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 22: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 23: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 24: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 25: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 26: China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 27: China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 28: China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 29: China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 30: Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 31: Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 32: Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 33: Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 34: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 35: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 36: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 37: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 38: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 39: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 40: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 41: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 42: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 43: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 44: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region

Table 45: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type

Table 46: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration

Table 47: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type

Table 48: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Clinical trials of cytotoxics as reported, by Phase

Figure 2: Number of clinical trials of cytotoxics, by Completion date ( 1993-2045)

Figure 3: North America Cytotoxic Drugs Market Value Share by Drug Type, 2022

Figure 4: North America Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2022 & 2028

Figure 5: North America Cytotoxic Drugs Market Attractiveness Index by Country, 2022 – 2028

Figure 6: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021

Figure 7: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028

Figure 8: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By U.S.

Figure 9: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By U.S.

Figure 10: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Canada

Figure 11: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Canada

Figure 12: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Alkylating drugs

Figure 13: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Alkylating drugs

Figure 14: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Antimetabolites

Figure 15: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Antimetabolites

Figure 16: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, ByforPlant Alkaloids

Figure 17: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Plant Alkaloids

Figure 18: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Antitumor Antibiotics

Figure 19: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Antitumor Antibiotics

Figure 20: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Others

Figure 21: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2021–2028, By Others

Figure 22: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Oral

Figure 23: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Oral

Figure 24: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Parenteral

Figure 25: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Parenteral

Figure 26: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Branded Drugs

Figure 27: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Branded Drugs

Figure 28: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Generic Drugs

Figure 29: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Generic Drugs

Figure 30: North America Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

Figure 31: North America Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration

Figure 32: North America Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

Figure 33: North America Cytotoxic Drugs Market Attractiveness Analysis, By End User

Figure 34: Latin America Cytotoxic Drugs Market Value Share by Drug Type, 2022

Figure 35: Latin America Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2022 & 2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Small-Molecule Injectable Market

Published : November 2021

Healthcare

Generic Oncology Drugs Market

Published : March 2022

Healthcare

Analgesics Market

Published : December 2021

Healthcare

Branded Generics Market

Published : August 2021

Google translate

Cytotoxic Drugs Market